Compounds > nalidixate sodium
Page last updated: 2024-09-24

nalidixate sodium

Description

tris(hydroxymethyl)phosphine: coupling reagent for enzyme immobilization [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID76001
CHEMBL ID279546
SCHEMBL ID235349
MeSH IDM0014438

Synonyms (25)

Synonym
phosphinidynetrimethanol
phosphinidynetrismethanol
tris(methanol)phosphine
trimethylolphosphine
einecs 220-445-6
tris(hydroxymethyl)phosphine
methanol, phosphinidynetris-
tris(hydroxymethyl)phosphine, 90%
bis(hydroxymethyl)phosphanylmethanol
CHEMBL279546
methanol, 1,1',1''-phosphinidynetris-
unii-y6tg7wf7oq
2767-80-8
methanol, phosphinidynetri-
y6tg7wf7oq ,
SCHEMBL235349
tris hydroxymethyl phosphine
JMXMXKRNIYCNRV-UHFFFAOYSA-N
tris-hydroxymethylphosphine
DTXSID0062634
AKOS028108502
mfcd00055382
J-016853
BCP07227
Q27294320

Bioassays (9)

Assay IDTitleYearJournalArticle
AID317470Cytotoxicity against human Daudi cells after 48 hrs by MTT assay2008Journal of medicinal chemistry, Feb-28, Volume: 51, Issue:4
In vitro antitumor activity of the water soluble copper(I) complexes bearing the tris(hydroxymethyl)phosphine ligand.
AID317468Cytotoxicity against human A549 cells after 48 hrs by MTT assay2008Journal of medicinal chemistry, Feb-28, Volume: 51, Issue:4
In vitro antitumor activity of the water soluble copper(I) complexes bearing the tris(hydroxymethyl)phosphine ligand.
AID317469Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay2008Journal of medicinal chemistry, Feb-28, Volume: 51, Issue:4
In vitro antitumor activity of the water soluble copper(I) complexes bearing the tris(hydroxymethyl)phosphine ligand.
AID317471Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay2008Journal of medicinal chemistry, Feb-28, Volume: 51, Issue:4
In vitro antitumor activity of the water soluble copper(I) complexes bearing the tris(hydroxymethyl)phosphine ligand.
AID317472Cytotoxicity against human A375 cells after 48 hrs by MTT assay2008Journal of medicinal chemistry, Feb-28, Volume: 51, Issue:4
In vitro antitumor activity of the water soluble copper(I) complexes bearing the tris(hydroxymethyl)phosphine ligand.
AID317467Cytotoxicity against human HL60 cells after 48 hrs by MTT assay2008Journal of medicinal chemistry, Feb-28, Volume: 51, Issue:4
In vitro antitumor activity of the water soluble copper(I) complexes bearing the tris(hydroxymethyl)phosphine ligand.
AID317473Cytotoxicity against human CaCo2 cells after 48 hrs by MTT assay2008Journal of medicinal chemistry, Feb-28, Volume: 51, Issue:4
In vitro antitumor activity of the water soluble copper(I) complexes bearing the tris(hydroxymethyl)phosphine ligand.
AID317478Cytotoxicity against human HeLa cells after 48 hrs by MTT assay2008Journal of medicinal chemistry, Feb-28, Volume: 51, Issue:4
In vitro antitumor activity of the water soluble copper(I) complexes bearing the tris(hydroxymethyl)phosphine ligand.
AID317474Cytotoxicity against human HCT15 cells after 48 hrs by MTT assay2008Journal of medicinal chemistry, Feb-28, Volume: 51, Issue:4
In vitro antitumor activity of the water soluble copper(I) complexes bearing the tris(hydroxymethyl)phosphine ligand.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (37.50)29.6817
2010's4 (50.00)24.3611
2020's1 (12.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceDescriptionRelationhip StrengthStudiesTrialsClassesRoles
glutaral[no description available]medium20dialdehydecross-linking reagent;
disinfectant;
fixative
chitosan[no description available]medium30
2,2-bis(bromomethyl)-1,3-propanediol[no description available]medium20primary alcohol
phosphine[no description available]medium20mononuclear parent hydride;
phosphanes;
phosphine		carcinogenic agent;
fumigant insecticide
D-fructopyranose[no description available]medium10cyclic hemiketal;
D-fructose;
fructopyranose		sweetening agent
lactose[no description available]medium10lactose
guanidine[no description available]medium10carboxamidine;
guanidines;
one-carbon compound
hepes[no description available]medium10HEPES;
organosulfonic acid
morpholinopropane sulfonic acid[no description available]medium10MOPS;
morpholines;
organosulfonic acid
phosphoric acid, trisodium salt[no description available]medium10sodium phosphate
gold[no description available]medium10copper group element atom;
elemental gold
alanine[no description available]medium10alanine zwitterion;
alanine;
L-alpha-amino acid;
proteinogenic amino acid;
pyruvate family amino acid		EC 4.3.1.15 (diaminopropionate ammonia-lyase) inhibitor;
fundamental metabolite
sucrose[no description available]medium10glycosyl glycosidealgal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
osmolyte;
Saccharomyces cerevisiae metabolite;
sweetening agent
1,3,5-triaza-7-phosphaadamantane[no description available]medium10
adamantane[no description available]medium10adamantanes;
polycyclic alkane
ConditionIndicatedRelationship StrengthStudiesTrials